✦ LIBER ✦

Factors affecting immunodetection of hepatitis B surface antigen recombinant mutants

✍ Scribed by Akhtar Ali; Sandra Pearce; Paul Coleman

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 135 KB
Volume: 79
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.20970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunoassay detection of hepatitis B sur

Immunoassay detection of hepatitis B surface antigen mutants

✍ Coleman, Paul F.; Jack Chen, Y.-C.; Mushahwar*, Isa K. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

The increasing use of hepatitis B vaccination has had an overwhelming positive impact on the prevention of hepatitis B viral infection. Mutations in the hepatitis B surface antigen (HBsAg) gene occur as a result of vaccine escape mutants, anti-hepatitis B surface antigen immunotherapy, or in chronic

Frequency of diagnostically significant

Frequency of diagnostically significant hepatitis B surface antigen mutants

✍ Mary C. Kuhns; Anne L. McNamara; Vera Holzmayer; Sheng C. Lou; Michael P. Busch 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

A novel deletion mutant of hepatitis B v

A novel deletion mutant of hepatitis B virus surface antigen

✍ Weinberger, Klaus M.; Zoulek, Gert; Bauer, Tanja; B�hm, Stephan; Jilg, Wolfgang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

HBsAg is the most important serological marker for acute or chronic hepatitis B. Nevertheless, there are reports of HBsAg-negative virus carriers, either with anti-HBc as the only marker for hepatitis B virus (HBV) infection or even positive for anti-HBs and anti-HBc. We report isolates from a patie

Licensed recombinant hepatitis B vaccine

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

✍ Norio Ogata; Paul J. Cote; Alessandro R. Zanetti; Roger H. Miller; Max Shapiro; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Controlled fed-batch fermentation of rec

Controlled fed-batch fermentation of recombinant Saccharomyces cerevisiae to produce hepatitis B surface antigen

✍ Jih-Han Hsieh; Kun-Yu Shih; Hsiang-Fu Kung; Ming Shiang; Lan-Ying Lee; Meng-Hsia 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

Bacterial expression of a human recombin

Bacterial expression of a human recombinant monoclonal antibody Fab fragment against hepatitis B surface antigen

✍ Maeda, F.; Nagatsuka, Y.; Ihara, S.; Aotsuka, S.; Ono, Y.; Inoko, H.; Takekoshi, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

The Fab fragment was cloned from the monoclonal cell line TAPC301-CL4, which was produced using the Epstein-Barr virus (EBV) transformation method. This cell line produces a human monoclonal antibody (CL4MAb) against the hepatitis B surface antigen (HBsAg). This MAb was shown to have hepatitis B vir